Literature DB >> 22461635

PRKAR1A gene analysis and protein kinase A activity in endometrial tumors.

A Tsigginou1, E Bimpaki, M Nesterova, A Horvath, S Boikos, C Lyssikatos, C Papageorgiou, C Dimitrakakis, A Rodolakis, C A Stratakis, A Antsaklis.   

Abstract

PRKAR1A codes for the type 1a regulatory subunit (RIα) of the cAMP-dependent protein kinase A (PKA), an enzyme with an important role in cell cycle regulation and proliferation. PKA dysregulation has been found in various tumors, and PRKAR1A-inactivating mutations have been reported in mostly endocrine neoplasias. In this study, we investigated PKA activity and the PRKAR1A gene in normal and tumor endometrium. Specimens were collected from 31 patients with endometrial cancer. We used as controls 41 samples of endometrium that were collected from surrounding normal tissues or from women undergoing gynecological operations for other reasons. In all samples, we sequenced the PRKAR1A-coding sequence and studied PKA subunit expression; we also determined PKA activity and cAMP binding. PRKAR1A mutations were not found. However, PKA regulatory subunit protein levels, both RIα and those of regulatory subunit type 2b (RIIβ), were lower in tumor samples; cAMP binding was also lower in tumors compared with normal endometrium (P<0.01). Free PKA activity was higher in tumor samples compared with that of control tissue (P<0.01). There are significant PKA enzymatic abnormalities in tumors of the endometrium compared with surrounding normal tissue; as these were not due to PRKAR1A mutations, other mechanisms affecting PKA function ought to be explored.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461635      PMCID: PMC4034123          DOI: 10.1530/ERC-11-0328

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  17 in total

1.  Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.

Authors:  Elise Meoli; Ioannis Bossis; Laure Cazabat; Manos Mavrakis; Anelia Horvath; Sotiris Stergiopoulos; Miriam L Shiferaw; Glawdys Fumey; Karine Perlemoine; Michael Muchow; Audrey Robinson-White; Frank Weinberg; Maria Nesterova; Yianna Patronas; Lionel Groussin; Jérôme Bertherat; Constantine A Stratakis
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

2.  Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas.

Authors:  C A Stratakis; L S Kirschner; J A Carney
Journal:  Am J Med Genet       Date:  1998-11-02

3.  PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.

Authors:  Audrey Robinson-White; Elise Meoli; Sotirios Stergiopoulos; Anelia Horvath; Sosipatros Boikos; Ioannis Bossis; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2006-03-28       Impact factor: 5.958

4.  A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.

Authors:  Lawrence S Kirschner; Donna F Kusewitt; Ludmila Matyakhina; William H Towns; J Aidan Carney; Heiner Westphal; Constantine A Stratakis
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.

Authors:  L S Kirschner; F Sandrini; J Monbo; J P Lin; J A Carney; C A Stratakis
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

6.  PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes.

Authors:  Audrey J Robinson-White; Wolfgang W Leitner; Eiman Aleem; Philipp Kaldis; Ioannis Bossis; Constantine A Stratakis
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

Review 7.  Aromatase expression in women's cancers.

Authors:  Serdar E Bulun; Evan R Simpson
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay.

Authors:  Elizabeth L Greene; Anelia D Horvath; Maria Nesterova; Christoforos Giatzakis; Ioannis Bossis; Constantine A Stratakis
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

9.  Extracellularly signal-regulated kinase activity in the human endometrium: possible roles in the pathogenesis of endometriosis.

Authors:  William Murk; Cem S Atabekoglu; Hakan Cakmak; Aylin Heper; Arzu Ensari; Umit A Kayisli; Aydin Arici
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

10.  Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.

Authors:  H M McDaid; M T Cairns; R J Atkinson; S McAleer; D P Harkin; P Gilmore; P G Johnston
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  2 in total

1.  Phosphorylation of the BNIP3 C-Terminus Inhibits Mitochondrial Damage and Cell Death without Blocking Autophagy.

Authors:  Katherine E Liu; William A Frazier
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

2.  Hypoxia and the hypoxia inducible factor 1α activate protein kinase A by repressing RII beta subunit transcription.

Authors:  Kristin Lucia; Yonghe Wu; Jose Monteserin Garcia; Anne Barlier; Michael Buchfelder; Wolfgang Saeger; Ulrich Renner; Günter K Stalla; Marily Theodoropoulou
Journal:  Oncogene       Date:  2020-02-28       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.